The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Alifirova V.M.

Sibirskiĭ gosudarstvennyĭ meditsinskiĭ universitet, Tomsk, Russia

Zhukova N.G.

Siberian State Medical University, Tomsk, Russia

Zhukova I.A.Жукова Ирина Александровна

Siberian State Medical University, Tomsk

Latypova A.V.

Siberian State Medical University, Tomsk, Russia

Titova M.A.

Sibirskiĭ gosudarstvennyĭ meditsinskiĭ universitet, Tomsk

Mironova Yu.S.

Siberian State Medical University, Tomsk, Russia

Izhboldina O.P.

Siberian State Medical University, Tomsk

Nikitina M.A.

Siberian State Medical University, Tomsk

Petrov V.A.

Siberian State Medical University, Tomsk, Russia

A role of the gastrointestinal tract microbiota in the pathogenesis of Parkinson’s disease

Authors:

Alifirova V.M., Zhukova N.G., Zhukova I.A.Жукова Ирина Александровна, Latypova A.V., Titova M.A., Mironova Yu.S., Izhboldina O.P., Nikitina M.A., Petrov V.A.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2016;116(11): 174‑179

DOI: 10.17116/jnevro2016116111174-179

Read: 861 times

Contact the author
Table of contents

A ROLE OF THE GASTROINTESTINAL TRACT MICROBIOTA IN THE PATHOGENESIS OF PARKINSON’S DISEASE
A ROLE OF THE GASTROINTESTINAL TRACT MICROBIOTA IN THE PATHOGENESIS OF PARKINSON’S DISEASE

To cite this article:

Alifirova VM, Zhukova NG, Zhukova IAЖукова Ирина Александровна, et al. A role of the gastrointestinal tract microbiota in the pathogenesis of Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2016;116(11):174‑179. (In Russ.)
https://doi.org/10.17116/jnevro2016116111174-179

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

Microbiota is a community of microorganisms, viruses, protozoa, colonizing the gut. There are tight phylogenetic relationships between the gut microbiota and the human body, the disturbance of which may lead to the CNS dysfunction as well as to the development of neurodegenerative diseases. This review focuses on general and specific aspects of the influence of gut microbiota on the pathogenesis of Parkinson’s disease (PD). Current theories and models of the relationship between microbiota and brain structures in PD are presented with a specific focus on neurochemical and immunological aspects of the problem.

Keywords:

neurodegenerative diseases
Parkinson’s disease
microbiota
microflora
the gastrointestinal tract

Authors:

Alifirova V.M.

Sibirskiĭ gosudarstvennyĭ meditsinskiĭ universitet, Tomsk, Russia

Zhukova N.G.

Siberian State Medical University, Tomsk, Russia

Zhukova I.A.Жукова Ирина Александровна

Siberian State Medical University, Tomsk

Latypova A.V.

Siberian State Medical University, Tomsk, Russia

Titova M.A.

Sibirskiĭ gosudarstvennyĭ meditsinskiĭ universitet, Tomsk

Mironova Yu.S.

Siberian State Medical University, Tomsk, Russia

Izhboldina O.P.

Siberian State Medical University, Tomsk

Nikitina M.A.

Siberian State Medical University, Tomsk

Petrov V.A.

Siberian State Medical University, Tomsk, Russia

Close metadata

References:

  1. Wirdefeldt K, Adami H-O, Cole P, Trichopoulos D, Mandel J. Epidemiology and etiology of Parkinson’s disease: a review of the evidence. Eur J Epidemiol. 2011;26(1):1-58. doi: 10.1007/s10654-011-9581-6
  2. Kaufmann H, Nahm K, Purohit D, Wolfe D. Autonomic failure as the initial presentation of Parkinson disease and dementia with Lewy bodies. Neurology. 2004;63(6):1093-1095. http://dx.doi.org/10.1212/01.wnl.0000138500.73671.dc
  3. Zis P, Martinez-Martin P, Sauerbier A, et al. Non-motor symptoms burden in treated and untreated early Parkinson’s disease patients: argument for non-motor subtypes. Eur J Neurol. 2015;22(8):1145-1150. doi: 10.1111/ene.12733
  4. Pfeiffer R. Intestinal Dysfunction in Parkinson’s Disease. In: Pfeiffer R, Bodis-Wollner I, eds. Parkinson’s Disease and Nonmotor Dysfunction. Current Clinical Neurology. Humana Press; 2013;155-171. doi: 10.1007/978-1-60761-429-6_10
  5. Goetze O, Nikodem A, Wiezcorek J, et al. Predictors of gastric emptying in Parkinson’s disease. Neurogastroenterology & Motility. 2006;18(5):369-375. doi: 10.1111/j.1365-2982.2006.00780.x
  6. Goetze O, Wieczorek J, Mueller T, Przuntek H, Schmidt WE, Woitalla D. Impaired gastric emptying of a solid test meal in patients with Parkinson’s disease using 13C-sodium octanoate breath test. Neuroscience Letters. 2005;375(3):170-173. doi: 10.1016/j.neulet.2004.11.007
  7. Abbott RD, Petrovitch H, White LR, et al. Frequency of bowel movements and the future risk of Parkinson’s disease. Neurology. 2001;57(3):456-462. doi: 10.1212/WNL.57.3.456
  8. Noyce AJ, Bestwick JP, Silveira-Moriyama L, et al. Meta-analysis of early nonmotor features and risk factors for Parkinson disease. Ann Neurol. 2012;72(6):893-901. doi: 10.1002/ana.23687
  9. Pavcovich LA, Yang M, Miselis RR, Valentino RJ. Novel role for the pontine micturition center, Barrington’s nucleus: evidence for coordination of colonic and forebrain activity. Brain research. 1998;784(1):355-361. doi: 10.1016/s0006-8993(97)01178-5
  10. Valentino RJ, Miselis RR, Pavcovich LA. Pontine regulation of pelvic viscera: pharmacological target for pelvic visceral dysfunctions. Trends in pharmacological sciences. 1999;20(6):253-260. doi: 10.1016/s0165-6147(99)01332-2
  11. Kim YS. Accumulation of Alpha-synuclein Causes Colonic Dysmotility Independently of Enteric Nervous Damage in the Early Stage of Parkinson’s Disease (Neurogastroenterol Motil 2012;24:425-436). Journal of Neurogastroenterology and Motility. 2013;19(2):264-266. doi: 10.5056/jnm.2013.19.2.264
  12. Masuda H, Asahina M, Oide T et al. Antemortem detection of colonic α-synuclein pathology in a patient with pure autonomic failure. J Neurol. 2014;261(12):2451-2452. doi: 10.1007/s00415-014-7529-y
  13. Forsyth CB, Shannon KM, Kordower JH, et al. Increased Intestinal Permeability Correlates with Sigmoid Mucosa alpha-Synuclein Staining and Endotoxin Exposure Markers in Early Parkinson’s Disease. PLoS ONE. 2011;6(12):28032. doi: 10.1371/journal.pone.0028032
  14. Malek N, Swallow D, Grosset KA, Anichtchik O, Spillantini M, Grosset DG. Alpha-synuclein in peripheral tissues and body fluids as a biomarker for Parkinson’s disease — a systematic review. Acta Neurologica Scandinavica 2014;130(2):59-72. doi: 10.1111/ane.12247
  15. Beach TG, Adler CH, Sue LI, et al. Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders. Acta neuropathologica. 2010;119(6):689-702. doi: 10.1007/s00401-010-0664-3
  16. Braak H, Ghebremedhin E, Rüb U, Bratzke H, Del Tredici K. Stages in the development of Parkinson’s disease-related pathology. Cell and tissue research. 2004;318(1):121-134. doi: 10.1007/s00441-004-0956-9
  17. Goldstein DS, Sewell L, Holmes C. Association of anosmia with autonomic failure in Parkinson disease. Neurology. 2010;74(3):245-251. doi: 10.1212/WNL.0b013e3181ca014c
  18. Hill JM, Clement C, Pogue AI, Bhattacharjee S, Zhao Y, Lukiw WJ. Pathogenic microbes, the microbiome, and Alzheimer’s disease (AD). Frontiers in Aging Neuroscience. 2014;6:127. doi: 10.3389/fnagi.2014.00127
  19. Grab DJ, Chakravorty SJ, van der Heyde H, Stins MF. How can microbial interactions with the blood — brain barrier modulate astroglial and neuronal function? Cellular Microbiology. 2011;13(10):1470-1478. doi: 10.1111/j.1462-5822.2011.01661.x
  20. Lema Tomé CM, Tyson T, Rey NL, Grathwohl S, Britschgi M, Brundin P. Inflammation and α-Synuclein’s Prion-like Behavior in Parkinson’s Disease—Is There a Link? Molecular Neurobiology. 2012;47(2):561-574. doi: 10.1007/s12035-012-8267-8
  21. Visanji NP, Brooks PL, Hazrati L-N, Lang AE. The prion hypothesis in Parkinson’s disease: Braak to the future. Acta Neuropathologica Communications. 2013;1:2-2. doi: 10.1186/2051-5960-1-2
  22. Braak H, Tredici KD, Rüb U, de Vos RA., Jansen Steur EN., Braak E. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiology of Aging. 24(2):197-211. doi: 10.1016/S0197-4580(02)00065-9
  23. Dickson RP, Erb-Downward JR, Huffnagle GB. The role of the bacterial microbiome in lung disease. Expert Review of Respiratory Medicine. Informa UK Limited; 2013;7(3):245-257. doi: 10.1586/ers.13.24
  24. Spasova DS, Surh CD. Blowing on Embers: Commensal Microbiota and Our Immune System. Frontiers in Immunology. 2014;5:318. doi: 10.3389/fimmu.2014.00318
  25. Bittinger K, Charlson ES, Loy E et al. Improved characterization of medically relevant fungi in the human respiratory tract using next-generation sequencing. Genome biology. 2014;15(10):487. doi: 10.1186/s13059-014-0487-y
  26. Montiel-Castro AJ, González-Cervantes RM, Bravo-Ruiseco G, Pacheco-López G. The microbiota-gut-brain axis: neurobehavioral correlates, health and sociality. Frontiers in Integrative Neuroscience. 2013;7:70. doi: 10.3389/fnint.2013.00070
  27. Sudo N, Chida Y, Aiba Y et al. Postnatal microbial colonization programs the hypothalamic — pituitary — adrenal system for stress response in mice. The Journal of Physiology. 2004;558(1):263-275. doi: 10.1113/jphysiol.2004.063388
  28. Stilling RM, Dinan TG, Cryan JF. Microbial genes, brain & behaviour — epigenetic regulation of the gut — brain axis. Genes, Brain and Behavior. 2014;13(1):69-86. doi: 10.1111/gbb.12109
  29. Luna RA, Foster JA. Gut brain axis: diet microbiota interactions and implications for modulation of anxiety and depression. Current opinion in biotechnology. 2015;32:35-41. doi: 10.1016/j.copbio.2014.10.007
  30. Daulatzai M. Chronic Functional Bowel Syndrome Enhances Gut-Brain Axis Dysfunction, Neuroinflammation, Cognitive Impairment, and Vulnerability to Dementia. Neurochem Res. 2014;39(4):624-644. doi: 10.1007/s11064-014-1266-6.
  31. Forsythe P, Bienenstock J, Kunze W. Vagal Pathways for Microbiome-Brain-Gut Axis Communication. In: Lyte M, Cryan JF, eds. Microbial Endocrinology: The Microbiota-Gut-Brain Axis in Health and Disease. Advances in Experimental Medicine and Biology. Springer New York; 2014;115-133. doi: 10.1007/978-1-4939-0897-4_5
  32. Marangell LB, Rush AJ, George MS et al. Vagus nerve stimulation (VNS) for major depressive episodes: one year outcomes. Biological Psychiatry. 2002;51(4):280-287. doi: 10.1016/S0006-3223(01)01343-9
  33. Indrio F, Riezzo G, Raimondi F, Di Mauro A, Francavilla R. Microbiota Involvement in the Gut—Brain Axis. Journal of Pediatric Gastroenterology and Nutrition. 2013;57. doi: 10.1097/01.mpg.0000441927.20931.d6
  34. Banks WA, Kastin AJ, Broadwell RD. Passage of Cytokines across the Blood-Brain Barrier. Neuroimmunomodulation. 1995;2(4):241-248. doi: 10.1159/000097202
  35. Wang Y, Kasper LH. The role of microbiome in central nervous system disorders. Brain, behavior, and immunity. 2014;38:1-12. doi: 10.1016/j.bbi.2013.12.015
  36. Berer K, Mues M, Koutrolos M, et al. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature. 2011;479(7374):538-541. doi: 10.1038/nature10554
  37. Berer K, Wekerle H, Krishnamoorthy G. B cells in spontaneous autoimmune diseases of the central nervous system. Molecular immunology. 2011;48(11):1332-1337. doi: 10.1016/j.molimm.2010.10.025
  38. Ezendam J, De Klerk A, Gremmer ER, Van Loveren H. Effects of Bifidobacterium animalis administered during lactation on allergic and autoimmune responses in rodents. Clinical & Experimental Immunology. 2008;154(3):424-431. doi: 10.1111/j.1365-2249.2008.03788.x
  39. Ochoa Repáraz J, Mielcarz DW, Begum Haque S, Kasper LH. Gut, bugs, and brain: role of commensal bacteria in the control of central nervous system disease. Annals of neurology. 2011;69(2):240-247. doi: 10.1002/ana.22344
  40. Kishan Kumar Nyati, Roopanshi Nyati. Role of Campylobacter jejuni Infection in the Pathogenesis of Guillain-Barré Syndrome: An Update. BioMed Research International. 2013;13. doi: 10.1155/2013/852195
  41. Kang D-W, Park JG, Ilhan ZE, Wallstrom G, LaBaer J, Adams JB et al. Reduced Incidence of Prevotella and Other Fermenters in Intestinal Microflora of Autistic Children. Gilbert JA, editor. PLoS ONE. Public Library of Science (PLoS); 2013;8(7):68322. doi: 10.1371/journal.pone.0068322
  42. Sandler RH, Finegold SM, Bolte ER, Buchanan CP, Maxwell AP, Vaisanen M-L et al. Short-Term Benefit From Oral Vancomycin Treatment of Regressive-Onset Autism. Journal of Child Neurology SAGE Publications. 2000;15(7):429-435. doi: 10.1177/088307380001500701
  43. Scheperjans F, Aho V, Pereira PAB, et al. Gut microbiota are related to Parkinson’s disease and clinical phenotype. Mov Disord. 2015;30(3):350-358. doi: 10.1002/mds.26069
  44. Keshavarzian A, Green SJ, Engen PA, et al. Colonic bacterial composition in Parkinson’s disease. Movement Disorders. 2015;30(10):1351-1360. doi: 10.1002/mds.26307
  45. Natale G, Pasquali L, Ruggieri S, Paparelli A, Fornai F. Parkinson’s disease and the gut: a well known clinical association in need of an effective cure and explanation. Neurogastroenterology & Motility. 2008;20(7):741-749. doi: 10.1111/j.1365-2982.2008.01162.x
  46. Willemze RA, Luyer MD, Buurman WA, de Jonge WJ. Neural reflex pathways in intestinal inflammation: hypotheses to viable therapy. Nature Reviews Gastroenterology & Hepatology. 2015. doi: 10.1038/nrgastro.2015.56
  47. Vizcarra JA, Wilson Perez HE, Espay AJ. The power in numbers: gut microbiota in Parkinson’s disease. Movement Disorders. 2015;30(3):296-298. doi: 10.1002/mds.26116
  48. Olanow CW, Wakeman DR, Kordower JH. Peripheral alpha-synuclein and Parkinson’s disease. Movement Disorders. 2014;29(8):963-966. doi: 10.1002/mds.25966
  49. Ulusoy A, Rusconi R, Pérez Revuelta BI, et al. Caudo-rostral brain spreading of α-synuclein through vagal connections. EMBO molecular medicine. 2013;5(7):1119-1127. doi: 10.1002/emmm.201302475
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.